CRL - Charles River Laboratories International, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/29/201812/30/201712/31/201612/26/2015
Total Revenue-1,857,6011,681,4321,363,302
Cost of Revenue1,423,4101,135,7321,023,331829,642
Gross Profit842,686721,869658,101533,660
Operating Expenses
Research Development----
Selling General and Administrative418,724365,436343,273279,376
Non Recurring----
Others----
Total Operating Expenses1,906,9641,542,5381,408,3031,133,247
Operating Income or Loss359,132315,063273,129230,055
Income from Continuing Operations
Total Other Income/Expenses Net-14,491-18,108-50,208-34,627
Earnings Before Interest and Taxes359,132315,063273,129230,055
Interest Expense--29,777-27,709-15,072
Income Before Tax-296,955222,921195,428
Income Tax Expense-171,36966,83543,391
Minority Interest-18,93617,01632,497
Net Income From Continuing Ops-125,586156,086152,037
Non-recurring Events
Discontinued Operations--137280-950
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-123,355154,765149,313
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-123,355154,765149,313